Exam (elaborations)
N5334 Final exam with verified answers
- Course
- Institution
N5334 Final exam with verified answers
[Show more]
Content preview
N5334 Final exam with verified answersPrescribing ,,basics ,,- ,,ANSWER: ,, ,,➡ ,,Prescribing ,,is ,,regulated ,,by ,,state ,,BON
Proper ,,RX ,,- ,,ANSWER: ,, ,,➡ ,,Providers ,,name ,,and ,,address, ,,Telephone
DEA
Pt ,,name/DOB/Addres
Name ,,of ,,Drug, ,,strength, ,,SIG(directions) ,,with ,,indication/Route ,,and ,,frequency, ,,Quantity ,,and ,,signature.
Drug ,,Schedules: ,,Most ,,addictive ,,to ,,least ,,- ,,ANSWER: ,, ,,➡ ,,1: ,,Heroin,LSD, ,,MJ
2: ,,hydrocodone, ,,cocaine, ,,Methamphetamine, ,,methadone, ,,oxycodone, ,,meperidine, ,,fentanyl, ,,adderall,
,,ritalin
3: ,,codeine, ,,ketamine, ,,testosterone
4: ,,xanax, ,,valium, ,,soma, ,,ambient, ,,tramadol
5: ,,antidiarrheal, ,,antitussives, ,,lomotil, ,,lyrica
Pharmicodyamics ,,- ,,ANSWER: ,, ,,➡ ,,The ,,effects ,,of ,,drug ,,on ,,the ,,body. ,,Receptors ,,are ,,large ,,molecules
,,usually ,,proteins, ,,that ,,interact ,,and ,,mediate ,,the ,,action ,,of ,,drugs
agonist ,,- ,,ANSWER: ,, ,,➡ ,,produce ,,receptor ,,stimulation ,,and ,,a ,,conformational ,,change ,,every ,,time ,,they
,,bind. ,,Do ,,not ,,need ,,all ,,available ,,receptors ,,to ,,produce ,,a ,,maximum ,,response
Partial ,,agonist ,,- ,,ANSWER: ,, ,,➡ ,,drugs ,,that ,,have ,,properties ,,in ,,b/w ,,those ,,of ,,full ,,agonist ,,and ,,antagonist.
,,They ,,bind ,,to ,,receptors ,,but ,,when ,,they ,,occupy ,,the ,,receptor ,,sites, ,,they ,,stimulate ,,only ,,some ,,of ,,the
,,receptors.
antagonist ,,- ,,ANSWER: ,, ,,➡ ,,drugs ,,with ,,affinity ,,for ,,a ,,receptor ,,but ,,with ,,no ,,intrinsic ,,activity. ,,Affinity
,,allows ,,the ,,antagonist ,,to ,,bind ,,to ,,receptors, ,,but ,,lack ,,of ,,intrinsic ,,activity ,,prevents ,,the ,,bound
,,antagonist ,,from ,,causing ,,receptor ,,activation. ,,The ,,block ,,action ,,of ,,drugs ,,(ex. ,,Narcan)
,Bioavailabity ,,- ,,ANSWER: ,, ,,➡ ,,% ,,of ,,administered ,,dosage ,,of ,,the ,,drug ,,that ,,survives ,,the ,,first ,,pass
,,through ,,the ,,liver ,,and ,,reaches ,,the ,,blood ,,stream
half ,,life ,,- ,,ANSWER: ,, ,,➡ ,,Time ,,required ,,for ,,the ,,amount ,,of ,,a ,,drug ,,in ,,the ,,body ,,to ,,decline ,,by ,,50%, ,,drugs
,,with ,,shorter ,,half ,,lives ,,must ,,be ,,administer ,,frequently. ,,4.5-5.5 ,,times ,,the ,,half ,,life ,,to ,,get ,,steady ,,state
,,and ,,to ,,be ,,limited ,,from ,,the ,,body
what ,,the ,,body ,,does ,,to ,,the ,,drug ,,- ,,ANSWER: ,, ,,➡ ,,absorption, ,,distribution, ,,metabolism, ,,excretion
Distribution ,,- ,,ANSWER: ,, ,,➡ ,,movement ,,of ,,absorbed ,,drug ,,in ,,bodily ,,fluids ,,throughout ,,the ,,body ,,to
,,target ,,tissue. ,,Properties ,,affecting: ,,lipid/water ,,solubility, ,,PH ,,affects ,,ionization ,,of ,,drug, ,,protein ,,binding,
,,size ,,of ,,molecule ,,(smaller ,,molecules ,,are ,,more ,,able ,,to ,,diffuse)
Tissue: ,,fat, ,,bone, ,,blood/brain ,,barrier ,,(only ,,lipid ,,soluble ,,will ,,pass), ,,placental ,,barrier ,,(many ,,drugs ,,can
,,pass)
Protein ,,binding ,,- ,,ANSWER: ,, ,,➡ ,,unbound ,,drug ,,is ,,free ,,which ,,is ,,active, ,,crosses ,,membrane. ,,Low ,,plasma
,,proteins ,,result ,,in ,,more ,,free ,,drug. ,,Competition: ,,when ,,2 ,,highly ,,bound ,,drugs ,,are ,,given ,,it ,,increases ,,the
,,level ,,of ,,both ,,drugs
Metabolism ,,- ,,ANSWER: ,, ,,➡ ,,take ,,place ,,in ,,the ,,liver ,,mostly. ,,Chemical ,,change ,,of ,,a ,,drug ,,structure ,,to: ,,
Enhance ,,excretion, ,,inactivate ,,the ,,drug, ,,increase ,,therapeutic ,,action, ,,active ,,a ,,prodrug ,,(inactive ,,until
,,metabolized ,,in ,,the ,,body ,,into ,,the ,,active ,,compound, ,,ex: ,,levodopa), ,,increase ,,or ,,decrease ,,toxicity
CYP450 ,,- ,,ANSWER: ,, ,,➡ ,,enzymes ,,constitutes ,,the ,,most ,,important ,,of ,,the ,,phase ,,I ,,metabolizing ,,enzymes
,,(account ,,for ,,about ,,75% ,,of ,,drug ,,metabolism ,,in ,,the ,,liver)
Phase ,,2: ,,conjugation ,,reaction ,,occur ,,leading ,,to ,,large ,,increases ,,in ,,hydrophilicity ,,of ,,the ,,substrates
,,rendering ,,them ,,more ,,readily ,,excretable
Substrate ,,- ,,ANSWER: ,, ,,➡ ,,an ,,agent ,,that ,,is ,,metabolized ,,by ,,an ,,enzyme ,,into ,,a ,,metabolite ,,and ,,product
,,and ,,eventually ,,excreted
,Inhibitors ,,- ,,ANSWER: ,, ,,➡ ,,compete ,,with ,,other ,,drugs ,,for ,,a ,,particular ,,enzyme ,,affecting ,,the ,,metabolism
,,(decreased) ,,of ,,the ,,substrate ,,and ,,decreases ,,the ,,excretion ,,of ,,the ,,substrate ,,and ,,increasing ,,the
,,circulating ,,drug
inducer ,,- ,,ANSWER: ,, ,,➡ ,,competes ,,with ,,other ,,drugs ,,for ,,a ,,particular ,,enzyme ,,affecting ,,metabolism ,,of
,,the ,,substrate ,,(increases) ,,decreasing ,,the ,,efficacy ,,of ,,the ,,drug
excretion ,,- ,,ANSWER: ,, ,,➡ ,,renal: ,,passive ,,glomerular ,,filtration, ,,active ,,tubular ,,secretion, ,,tubular
,,reabsorption, ,,gi ,,tract, ,,lung, ,,sweat ,,and ,,salivary, ,,mammary
genomics ,,- ,,ANSWER: ,, ,,➡ ,,study ,,of ,,the ,,complete ,,set ,,of ,,genetic ,,information ,,present ,,in ,,a ,,cell, ,,an
,,organism, ,,or ,,species
pharmacogenetics ,,- ,,ANSWER: ,, ,,➡ ,,the ,,study ,,of ,,the ,,influence ,,of ,,hereditary ,,factors ,,on ,,the ,,response ,,of
,,individual ,,organisms ,,to ,,drugs, ,,and ,,the ,,study ,,of ,,variations ,,of ,,DNA ,,and ,,RNA ,,characteristics ,,as ,,related
,,to ,,drug ,,response
Pharmacogenetics ,,tests ,,- ,,ANSWER: ,, ,,➡ ,,Mentioned ,,on ,,drug ,,labels ,,can ,,be ,,classified ,,as ,,"test ,,required,"
,,"test ,,recommended," ,,and ,,"information ,,only." ,,Currently, ,,four ,,drugs ,,are ,,required ,,to ,,have
,,pharmacogenetics ,,testing ,,performed ,,before ,,they ,,are ,,prescribed: ,,cetuximab, ,,trastuzumab, ,,maraviroc
,,and ,,dasatinib
wafarin, ,,carbamazepine, ,,valproic ,,acid ,,and ,,abacavir ,,are ,,recommended ,,to ,,tests ,,prior ,,to ,,initial ,,dosing
Carbamazepine ,,and ,,Asisans ,,- ,,ANSWER: ,, ,,➡ ,,Initiating ,,carbamazepine ,,therapy ,,in ,,these ,,patients ,,(allele
,,HLA-B*1502) ,,are ,,at ,,high ,,risk ,,for ,,developing ,,Steven ,,Johnson ,,syndrome ,,or ,,toxic ,,epidermal ,,necrolysis
,,(TEN)
The ,,ability ,,of ,,the ,,anesthetic ,,to ,,penetrate ,,the ,,axon ,,membrane ,,is ,,determined ,,by ,,3 ,,properties. ,,What
,,are ,,they? ,,- ,,ANSWER: ,, ,,➡ ,,Molecular ,,size, ,,Lipid ,,solubility, ,,degree ,,of ,,ionization ,,at ,,tissue ,,pH
Why ,,is ,,epinephrine ,,given ,,with ,,local ,,anesthetics? ,,- ,,ANSWER: ,, ,,➡ ,,Decreases ,,local ,,blood ,,flow
,,(decreased ,,risk ,,of ,,bleeding)
, Delays ,,systemic ,,absorption ,,of ,,the ,,anesthetic
prolongs ,,anesthesia
reduces ,,the ,,risk ,,of ,,toxicity
What ,,is ,,the ,,most ,,widely ,,used ,,local ,,anesthetic? ,,- ,,ANSWER: ,, ,,➡ ,,Lidocaine
What ,,is ,,a ,,possible ,,fatal ,,reaction ,,to ,,benzocaine ,,- ,,ANSWER: ,, ,,➡ ,,Methemoglobinemia
What ,,is ,,included ,,in ,,application ,,guidelines ,,for ,,topical ,,anesthetics ,,- ,,ANSWER: ,, ,,➡ ,,avoid ,,wrapping ,,the
,,site ,,and ,,heating ,,the ,,site, ,,avoid ,,application ,,to ,,open ,,skin
Which ,,medication ,,will ,,not ,,cause ,,rebound ,,headaches ,,from ,,overuse? ,,- ,,ANSWER: ,, ,,➡ ,,propranolol
,,(preventative)
What ,,is ,,the ,,best ,,option ,,for ,,menstural ,,migraine? ,,- ,,ANSWER: ,, ,,➡ ,,low ,,dose ,,estrogen ,,about ,,3 ,,days
,,prior ,,to ,,menses
What ,,food ,,can ,,trigger ,,migraines? ,,- ,,ANSWER: ,, ,,➡ ,,Hot ,,dog ,,d/t ,,nitrates
What ,,medication ,,is ,,a ,,Seratonin ,,1B1D ,,receptor ,,agonist? ,,- ,,ANSWER: ,, ,,➡ ,,Sumatriptan
Butterbur ,,can ,,help ,,as ,,prevention ,,for ,,migraine ,,therapy. ,,What ,,side ,,effect ,,can ,,occur? ,,- ,,ANSWER: ,, ,,➡
,,Liver ,,damage
What ,,are ,,the ,,3 ,,main ,,classes ,,of ,,opiod ,,receptors? ,,- ,,ANSWER: ,, ,,➡ ,,Mu ,,kappa ,,delta
Which ,,of ,,the ,,following ,,will ,,reserve ,,he ,,effects ,,caused ,,by ,,opioid ,,agonist? ,,- ,,ANSWER: ,, ,,➡ ,,naloxone
Which ,,of ,,the ,,medications ,,are ,,used ,,to ,,treat ,,OIC? ,,- ,,ANSWER: ,, ,,➡ ,,Naloxegol, ,,methylinaltrexone,
,,lubiprostone
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Fordenken. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $13.49. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
72349 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now